Form 4: Summit Therapeutics CFO Reports Stock Transaction
Insider Transaction (Form 4)
Manmeet Singh Soni, COO and CFO and a Director of Summit Therapeutics Inc., reported multiple transactions in common stock on November 16, 2026.
Summary
- Option exercise/conversion: acquired 100,000 Common Stock at $1.37 ($137,000) on November 16, 2026; holds 3,224,375 after (Direct).
- Option exercise/conversion: disposed of 100,000 Stock Option (right to buy) on November 16, 2026; holds 100,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Manmeet Singh Soni — Director, Officer (COO and CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-16 | Option exercise/conversion | Common Stock | 100,000 | $1 | $137.0K | 3,224,375 |
| 2026-11-16 | Option exercise/conversion | Stock Option (right to buy) | 100,000 | — | — | 100,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-16 | Option exercise/conversion (100,000 shares) |
| 2026-11-16 | Option exercise/conversion (100,000 shares) |
Keywords
insider transaction, Form 4, SMMT, Summit Therapeutics Inc., neutral, Manmeet Singh Soni
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.